CHADS2-VASc skorunun primer percutan koroner girişim yapılan ST elevasyonlu miyokart enfarktüslü hastalarda ST segment rezolusyonunu öngörmedeki yararlılığı
Amaç: Tıkalı koroner arterde hızlı koroner kan akımın sağlanması, ST yükselmeli miyokard infarktüsü (STEMI) tedavisinin temel amacıdır. Her ne kadar koroner kan akımı sağlanmış olsa da, çoğunlukla mikrovasküler düzeyde yetersiz miyokard reperfüzyonu çok sayıda hastada saptanmıştır. Elektrokardiyografik olarak işlem sonrası ST-segment rezolusyonunu (STR) ölçmek reperfüzyon başarısını değerlendirilmek için kolay ve iyi bir göstergedir. CHA2DS2-VASc risk skoru, valvüler olmayan AF hastalarında tromboembolizm riskini tahmin etmek için kullanılır. STEMI ile başvuran hastalarda STR yetersizliğinin gelişmesini öngörmedeki yararı bilinmemektedir. STEMI sonrası STR’ nun değerlendirilmesinde CHA2DS2-VASc skorunun prediktif değerinin araştırılması amaçlanmıştır.Yöntem: CHA2DS2-VASc ve CHA2DS2-VASc -HS puanlarının prediktif değerini test etmek için klinik ve laboratuvar parametrelerini içeren modeller yapıldı. Hastalar STR>% 70 olan ve olmayan olarak iki gruba ayrılmıştır. STR başarısızlığının öngördürücüleri, çok değişkenli regresyon analizi ile belirlendi.Bulgular: Çalışmada STR saptanmayan hastalarda CHA2DS2-VASc ve CHA2DS2-VASc-HS skorları anlamlı olarak yüksekti. Çoklu regresyon analizi, CHA2DS2-VASc-HS skoru, Anterior STEMI, pik CK-MB seviyesi ve perkütan koroner girişim zamanının STEMI ile başvuran hastalarda STR yetersizliği gelişimi ile ilişkili olduğunu gösterdi. ROC eğrisi analizi, CHA2DS2-VASc ve CHA2DS2-VASc –HS skorlarının STR başarısızlığı için öngördürücü olduğunu göstermiştir. Sonuç: CHA2DS2-VASc ve CHA2DS2-VASc -HS skorları, STEMI sunan hastalarda STR yetmezliğini öngörmektedir.
Usefulness of the CHA2DS2-VASc Score to Predict “St Segment Resolution Failure” In Patients Treated With Primary Percutaneous Coronary Intervention for St-Segment Elevation Myocardial Infarction
Background: Rapid supply of coronary blood flow in the occluded coronary artery is the principle aim of early ST-elevation myocardial infarction (STEMI) therapy. Although coronary blood flow has been supplied, insufficient myocardial reperfusion mainly at the level of micro vascular circulation has been assessed a large number of patients. Electrocardiographically by measuring ST-segment resolution (STR) after procedure is an easy and good indicator for the evaluation of reperfusion failure. The CHA2DS2-VASc risk score is used to predict the risk of thromboembolism in non-valvular AF patients. Its usefulness in predicting AF in the development of STR failure in patients presenting with STEMI is unknown. We evaluated the predictive value of the CHA2DS2-VASc score in patients with STR failure following STEMI.Methods: Models including clinical and laboratory parameters were constructed to test the predictive value of CHA2DS2-VASc and CHA2DS2-VASc -HS scores. Patients were divided into two groups: those with STR> 70 % and those without STR> 70. Predictors of STR failure were determined by multivariate regression analysis.Results: Multiple regression analysis showed that CHA2DS2-VASc-HS score, Anterior STEMI, peak CK-MB level and symptom to percutaneous coronary intervention time were associated with development of STR failure in patients presenting with STEMI. ROC curve analyses showed that CHA2DS2-VASc and CHA2DS2-VASc -HS scores were significant predictors for STR failure. Conclusion: CHA2DS2-VASc and CHA2DS2-VASc -HS scores predict STR failure in patients presenting STEMI.
___
- 1. Neumann F-J, Sousa-Uva M, Ahlsson A, et al. Group
ESCSD. 2018 ESC/EACTS Guidelines on myocardial
revascularization. European heart journal
2018:ehy394-ehy394.
- 2. Brener SJ, Dizon JM, Mehran R, et al. Complementary
prognostic utility of myocardial blush grade and STsegment resolution after primary percutaneous
coronary intervention: analysis from the HORIZONSAMI trial. American heart journal 2013; 166: 676-83.
- 3. Sarkar A, Lee JJ. TIMI Grade Flow StatPearls. Treasure
Island (FL), 2018.
- 4. Somitsu Y, Nakamura M, Degawa T, Yamaguchi T.
Prognostic value of slow resolution of ST-segment
elevation following successful direct percutaneous
transluminal coronary angioplasty for recovery of left
ventricular function. The American journal of
cardiology 1997; 80: 406-410.
- 5. Sutton A, Campbell P, Grech E, et al. Failure of
thrombolysis: experience with a policy of early
angiography and rescue angioplasty for
electrocardiographic evidence of failed thrombolysis.
Heart 2000; 84: 197-204.
- 6. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC
Guidelines for the management of atrial fibrillation
developed in collaboration with EACTS. Eur Heart J
2016; 37: 2893-962.
- 7. Kilic S, Kocabas U, Can LH, Yavuzgil O, Çetin M, Zoghi
M. Predictive value of CHA2DS2-VASc and CHA2DS2-
VASc-HS scores for failed reperfusion after
thrombolytic therapy in patients with ST-elevation
myocardial ınfarction. Cardiology journal 2013.
- 8. Aksoy F, Bas HA, Bagci A, Oskay T. The CHA2DS2-VASc
score for predicting atrial fibrillation in patients
presenting with ST elevation myocardial infarction:
prospective observational study. Sao Paulo Med J 2019;
137: 248-54.
- 9. Aksoy F, Guler S, Kahraman F, Oskay T, Varol E. The
Relation Between Echocardiographic Epicardial Fat
Thickness and CHA2DS2-VASc Score in Patients with
Sinus Rhythm. Braz J Cardiovasc Surg 2019; 34: 41-7.
- 10. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal
definition of myocardial infarction. European heart
journal 2012; 33: 2551-67.
- 11. Lee A, Sadick N, Ng A, Hsieh C, Ross D. Prognostic
implication of ST‐segment resolution following primary
percutaneous transluminal coronary angioplasty for
ST‐elevation acute myocardial infarction. Internal
medicine journal 2004; 34: 551-6.
- 12. Members ATF, Steg PG, James SK, et al. ESC
Guidelines for the management of acute myocardial
infarction in patients presenting with ST-segment
elevation: The Task Force on the management of STsegment elevation acute myocardial infarction of the
European Society of Cardiology (ESC). European heart
journal 2012; 33: 2569-19.
- 13. Folland ED, Parisi AF. Noninvasive evaluation of left
ventricular function: the ejection fraction. Compr Ther
1979; 5: 47-54.
- 14. DeLong ER, DeLong DM, Clarke-Pearson DL.
Comparing the areas under two or more correlated
receiver operating characteristic curves: a
nonparametric approach. Biometrics 1988: 837-45.
- 15. Bozbay M, Uyarel H, Cicek G, et al. CHA2DS2-VASc
score predicts in-hospital and long-term clinical
outcomes in patients with ST-segment elevation
myocardial infarction who were undergoing primary
percutaneous coronary intervention. Clinical and
Applied Thrombosis/Hemostasis 2017; 23: 132-8.
- 16. Cetin M, Cakici M, Zencir C, et al. Prediction of
coronary artery disease severity using CHADS2 and
CHA2DS2-VASc scores and a newly defined CHA2DS2-
VASc-HS score. The American journal of cardiology
2014; 113: 950-6.
- 17. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ.
Refining clinical risk stratification for predicting stroke
and thromboembolism in atrial fibrillation using a
novel risk factor-based approach: the euro heart survey
on atrial fibrillation. Chest 2010; 137: 263-72.
- 18. Tousoulis D, Antoniades C, Stefanadis C. Assessing
inflammatory status in cardiovascular disease. Heart
2007; 93: 1001-1007.
- 19. Yilmaz S, Akboga MK, Aras D, Topaloglu S. Evaluation
of the predictive value of CHA2DS2-VASc score for InStent Restenosis. Angiology 2018; 69: 38-42.
- 20. Woo JS, Cho JM, Kim SJ, Kim MK, Kim CJ. Combined
assessments of biochemical markers and ST-segment
resolution provide additional prognostic information
for patients with ST-segment elevation myocardial
infarction. Korean circulation journal 2011; 41: 372-8.
- 21. Iwakura K, Ito H, Ikushima M, et al. Association
between hyperglycemia and the no-reflow
phenomenon inpatients with acute myocardial
infarction. Journal of the American College of
Cardiology 2003; 41: 1-7.
- 22. Marfella R, Esposito K, Giunta R, et al. Circulating
adhesion molecules in humans: role of hyperglycemia
and hyperinsulinemia. Circulation 2000; 101: 2247-51.
- 23. Booth G, Stalker TJ, Lefer AM, Scalia R. Elevated
ambient glucose induces acute inflammatory events in
the microvasculature: effects of insulin. American
Journal of Physiology-Endocrinology And Metabolism
2001; 280: E848-E856.
- 24. Engler RL, Dahlgren MD, Morris DD, Peterson M,
Schmid-Schonbein G. Role of leukocytes in response to
acute myocardial ischemia and reflow in dogs.
American Journal of Physiology-Heart and Circulatory
Physiology 1986; 251: H314-H323.
- 25. Ota S, Tanimoto T, Orii M, et al. Association between
hyperglycemia at admission and microvascular
obstruction in patients with ST-segment elevation
myocardial infarction. Journal of cardiology 2015; 65:
272-7.
- 26. Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year
prognostic value of no-reflow phenomenon after
percutaneous coronary intervention in patients with
acute myocardial infarction. Journal of the American
College of Cardiology 2010; 55: 2383-9.
- 27. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic
significance of microvascular obstruction by magnetic
resonance imaging in patients with acute myocardial
infarction. Circulation 1998; 97: 765-72.
- 28. Tang EW, Wong C-K, Herbison P. Global Registry of
Acute Coronary Events (GRACE) hospital discharge risk
score accurately predicts long-term mortality post
acute coronary syndrome. American heart journal
2007; 153: 29-35.
- 29. Mrdovic I, Savic L, Krljanac G, et al. Predicting 30-day
major adverse cardiovascular events after primary
percutaneous coronary intervention. The RISK-PCI
score. International journal of cardiology 2013; 162:
220-7.
- 30. Roffi M, Patrono C, Collet JP, et al, Group ESCSD. 2015
ESC Guidelines for the management of acute coronary
syndromes in patients presenting without persistent
ST-segment elevation: Task Force for the Management
of Acute Coronary Syndromes in Patients Presenting
without Persistent ST-Segment Elevation of the
European Society of Cardiology (ESC). European heart
journal 2016; 37: 267-315.